However, decreased expression levels of CD80, CD86 and MHC class II were observed in the lung DCs of the mice in the anti-NGF group, as compared with those in the asthma and control-IgG groups, despite increased serum levels of IFN-γ. This evidence concerns the gene CD86 and asthma.